118 related articles for article (PubMed ID: 16842893)
1. Nano- and microparticles as adjuvants in vaccine design: success and failure is related to host natural antibodies.
Sinyakov MS; Dror M; Lublin-Tennenbaum T; Salzberg S; Margel S; Avtalion RR
Vaccine; 2006 Oct; 24(42-43):6534-41. PubMed ID: 16842893
[TBL] [Abstract][Full Text] [Related]
2. Novel immunoadjuvants based on cationic lipid: Preparation, characterization and activity in vivo.
Lincopan N; Espíndola NM; Vaz AJ; da Costa MH; Faquim-Mauro E; Carmona-Ribeiro AM
Vaccine; 2009 Sep; 27(42):5760-71. PubMed ID: 19664738
[TBL] [Abstract][Full Text] [Related]
3. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations.
Berner VK; Sura ME; Hunter KW
Appl Microbiol Biotechnol; 2008 Oct; 80(6):1053-61. PubMed ID: 18677470
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization of Carassius auratus with modified recombinant A-layer proteins entrapped in alginate beads.
Maurice S; Nussinovitch A; Jaffe N; Shoseyov O; Gertler A
Vaccine; 2004 Dec; 23(4):450-9. PubMed ID: 15530693
[TBL] [Abstract][Full Text] [Related]
5. Atypical furunculosis vaccines for Atlantic cod (Gadus morhua); vaccine efficacy and antibody responses.
Lund V; Arnesen JA; Mikkelsen H; Gravningen K; Brown L; Schrøder MB
Vaccine; 2008 Dec; 26(52):6791-9. PubMed ID: 18951938
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
[TBL] [Abstract][Full Text] [Related]
7. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
[TBL] [Abstract][Full Text] [Related]
8. Antigen coupled with Lewis-x trisaccharides elicits potent immune responses in mice.
Hsu SC; Tsai TH; Kawasaki H; Chen CH; Plunkett B; Lee RT; Lee YC; Huang SK
J Allergy Clin Immunol; 2007 Jun; 119(6):1522-8. PubMed ID: 17353042
[TBL] [Abstract][Full Text] [Related]
9. Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity.
Andrianov AK; Marin A; Roberts BE
Biomacromolecules; 2005; 6(3):1375-9. PubMed ID: 15877355
[TBL] [Abstract][Full Text] [Related]
10. Multiple whole bacterial antigens in polyvalent vaccine may result in inhibition of specific responses in rainbow trout (Oncorhynchus mykiss).
Nikoskelainen S; Verho S; Järvinen S; Madetoja J; Wiklund T; Lilius EM
Fish Shellfish Immunol; 2007 Mar; 22(3):206-17. PubMed ID: 16849036
[TBL] [Abstract][Full Text] [Related]
11. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
[TBL] [Abstract][Full Text] [Related]
12. Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.
Ophorst OJ; Radosević K; Klap JM; Sijtsma J; Gillissen G; Mintardjo R; van Ooij MJ; Holterman L; Companjen A; Goudsmit J; Havenga MJ
Vaccine; 2007 Aug; 25(35):6501-10. PubMed ID: 17646036
[TBL] [Abstract][Full Text] [Related]
13. Influence of carrier proteins on the immunologic response to haptenic antitetrodotoxin vaccine.
Xu QH; Zhao XN; Cheng JP; Wei CH; Zhang QH; Rong KT
Bioconjug Chem; 2006; 17(6):1508-13. PubMed ID: 17105230
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
15. The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance.
Hunter R; Strickland F; Kézdy F
J Immunol; 1981 Sep; 127(3):1244-50. PubMed ID: 7264301
[TBL] [Abstract][Full Text] [Related]
16. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
17. The perfect mix: recent progress in adjuvant research.
Guy B
Nat Rev Microbiol; 2007 Jul; 5(7):505-17. PubMed ID: 17558426
[TBL] [Abstract][Full Text] [Related]
18. Vaccine immunopotentiators of the future.
Schijns VE; Degen WG
Clin Pharmacol Ther; 2007 Dec; 82(6):750-5. PubMed ID: 17914440
[TBL] [Abstract][Full Text] [Related]
19. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
[TBL] [Abstract][Full Text] [Related]
20. Chemical adjuvants for plasmid DNA vaccines.
Greenland JR; Letvin NL
Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
